Literature DB >> 16423046

OX40 interactions in gastrointestinal nematode infection.

Michelle X Ierna1, Hannah E Scales, Herbert Schwarz, Campbell Bunce, Anne McIlgorm, Paul Garside, Catherine E Lawrence.   

Abstract

The immune expulsion of gastrointestinal nematode parasites is usually associated with T helper type 2 (Th2) responses, but the effector mechanisms directly responsible for parasite loss have not been elucidated. The intestinal inflammatory response accompanying infection with gastrointestinal helminths is thought to be a contributory factor leading to the expulsion of the parasite. However, we have shown that the intestinal inflammation, which is controlled by interleukin (IL)-4, is not required for parasite expulsion. OX40-OX40 ligand (L) signals have been shown to be important for the development of Th2 immune responses but are also involved in a number of inflammatory diseases including those of the intestine. Here, we have investigated the effect of OX40 and OX40L fusion protein treatment on the induction of protective Th2 responses and enteropathy following infection with the gastrointestinal nematode Trichinella spiralis. Treatment with an OX40-immunoglobulin (Ig) blocking fusion protein resulted in enhanced expulsion of the parasite and an increase in the accompanying mastocytosis, despite unaltered levels of Th2 cytokines. Furthermore, there was a delay in the villus atrophy and crypt hyperplasia usually associated with this infection. In contrast, levels of Th2 cytokines were greatly up-regulated in mice treated with an OX40L-Ig activating fusion protein, yet the expulsion of the parasite and the enteropathy were unaffected. Therefore, OX40 ligation potentiates the Th2 response without enhancing host protective immune responses, whereas blocking the OX40-OX40L interaction enhances host protection without promoting Th2 cytokine responses during Trichinella spiralis infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16423046      PMCID: PMC1782197          DOI: 10.1111/j.1365-2567.2005.02271.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  55 in total

1.  Immunotherapy with OX40L-Fc or anti-CTLA-4 enhances local tissue responses and killing of Leishmania donovani.

Authors:  Soombul Zubairi; Stephanie L Sanos; Sue Hill; Paul M Kaye
Journal:  Eur J Immunol       Date:  2004-05       Impact factor: 5.532

2.  T cell proliferation by direct cross-talk between OX40 ligand on human mast cells and OX40 on human T cells: comparison of gene expression profiles between human tonsillar and lung-cultured mast cells.

Authors:  Jun-ichi Kashiwakura; Hidenori Yokoi; Hirohisa Saito; Yoshimichi Okayama
Journal:  J Immunol       Date:  2004-10-15       Impact factor: 5.422

3.  Critical role for OX40 ligand in the development of pathogenic Th2 cells in a murine model of asthma.

Authors:  Akihiko Hoshino; Yoshitaka Tanaka; Hisaya Akiba; Yumiko Asakura; Yasuo Mita; Takanobu Sakurai; Akiko Takaoka; Shiro Nakaike; Naoto Ishii; Kazuo Sugamura; Hideo Yagita; Ko Okumura
Journal:  Eur J Immunol       Date:  2003-04       Impact factor: 5.532

4.  Constitutive OX40/OX40 ligand interaction induces autoimmune-like diseases.

Authors:  Kazuko Murata; Masato Nose; Lishomwa C Ndhlovu; Takayuki Sato; Kazuo Sugamura; Naoto Ishii
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

5.  OX40 (CD134) and OX40 ligand interaction plays an adjuvant role during in vivo Th2 responses.

Authors:  Naoto Ishii; Lishomwa C Ndhlovu; Kazuko Murata; Takayuki Sato; Masahito Kamanaka; Kazuo Sugamura
Journal:  Eur J Immunol       Date:  2003-09       Impact factor: 5.532

Review 6.  Is there a common mechanism of gastrointestinal nematode expulsion?

Authors:  Catherine E Lawrence
Journal:  Parasite Immunol       Date:  2003-05       Impact factor: 2.280

7.  Mouse mast cell protease-1 is required for the enteropathy induced by gastrointestinal helminth infection in the mouse.

Authors:  Catherine E Lawrence; Yvonne Y W Paterson; Steven H Wright; Pamela A Knight; Hugh R P Miller
Journal:  Gastroenterology       Date:  2004-07       Impact factor: 22.682

8.  Effect of inducible costimulator blockade on the pathological and protective immune responses induced by the gastrointestinal helminth Trichinella spiralis.

Authors:  Hannah E Scales; Michelle X Ierna; Jose-Carlos Gutierrez-Ramos; Anthony J Coyle; Paul Garside; Catherine E Lawrence
Journal:  Eur J Immunol       Date:  2004-10       Impact factor: 5.532

9.  OX40 ligation on activated T cells enhances the control of Cryptococcus neoformans and reduces pulmonary eosinophilia.

Authors:  Ian R Humphreys; Lorna Edwards; Gerhard Walzl; Aaron J Rae; Gordon Dougan; Sue Hill; Tracy Hussell
Journal:  J Immunol       Date:  2003-06-15       Impact factor: 5.422

10.  A critical role for OX40 in T cell-mediated immunopathology during lung viral infection.

Authors:  Ian R Humphreys; Gerhard Walzl; Lorna Edwards; Aaron Rae; Sue Hill; Tracy Hussell
Journal:  J Exp Med       Date:  2003-10-20       Impact factor: 14.307

View more
  4 in total

Review 1.  Control of immunity by the TNFR-related molecule OX40 (CD134).

Authors:  Michael Croft
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

2.  OX40 Expression in Eosinophils Aggravates OVA-Induced Eosinophilic Gastroenteritis.

Authors:  Longwei Xu; Dan Tian; Minsi Zhou; Jiuyue Ma; Guangyong Sun; Hua Jin; Mingyang Li; Dong Zhang; Jing Wu
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

3.  OX40L-OX40 Interactions: A Possible Target for Gastrointestinal Autoimmune Diseases.

Authors:  Tahrin Mahmood; Ping-Chang Yang
Journal:  N Am J Med Sci       Date:  2012-11

4.  Functional investigation of a QTL affecting resistance to Haemonchus contortus in sheep.

Authors:  Guillaume Sallé; Carole Moreno; Simon Boitard; Julien Ruesche; Aurélie Tircazes-Secula; Frédéric Bouvier; Mathias Aletru; Jean-Louis Weisbecker; Françoise Prévot; Jean-Paul Bergeaud; Cathy Trumel; Christelle Grisez; Emmanuel Liénard; Philippe Jacquiet
Journal:  Vet Res       Date:  2014-06-17       Impact factor: 3.683

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.